Assenagon Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-140,205
| Closed | -$457K | – | 1405 |
|
|
2024
Q2 | $457K | Buy |
140,205
+70,060
| +100% | +$228K | ﹤0.01% | 1217 |
|
|
2024
Q1 | $372K | Sell |
70,145
-14,894
| -18% | -$78.9K | ﹤0.01% | 1215 |
|
|
2023
Q4 | $368K | Buy |
85,039
+15,897
| +23% | +$68.8K | ﹤0.01% | 1245 |
|
|
2023
Q3 | $182K | Sell |
69,142
-154,179
| -69% | -$405K | ﹤0.01% | 1299 |
|
|
2023
Q2 | $788K | Buy |
223,321
+30,127
| +16% | +$106K | ﹤0.01% | 989 |
|
|
2023
Q1 | $597K | Buy |
193,194
+27,088
| +16% | +$83.7K | ﹤0.01% | 1146 |
|
|
2022
Q4 | $703K | Hold |
166,106
| – | – | ﹤0.01% | 1063 |
|
|
2022
Q3 | $394K | Sell |
166,106
-21,384
| -11% | -$50.7K | ﹤0.01% | 1098 |
|
|
2022
Q2 | $534K | Buy |
187,490
+162,531
| +651% | +$463K | ﹤0.01% | 1166 |
|
|
2022
Q1 | $72K | Sell |
24,959
-354,180
| -93% | -$1.02M | ﹤0.01% | 1338 |
|
|
2021
Q4 | $1.15M | Buy |
+379,139
| New | +$1.15M | ﹤0.01% | 950 |
|
|
2019
Q4 | – | Sell |
-97,894
| Closed | -$1.05M | – | 852 |
|
|
2019
Q3 | $1.05M | Buy |
+97,894
| New | +$1.05M | 0.01% | 496 |
|